Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BI-1206 |
Trade Name | |
Synonyms | BI1206|BI 1206 |
Drug Descriptions |
BI-1206 binds to Fc gamma receptor IIB (CD32B) and blocks internalization of CD20 antibodies, which potentially results in enhanced CD20 antibody activity in tumor cells (Intl. Conf. on Malig. Lymphoma, vol. 32 (S2), pg num.: 520-521). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C156458 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BI-1206 | BI-1206 | 0 | 0 |
BI-1206 + Pembrolizumab | BI-1206 Pembrolizumab | 0 | 1 |
BI-1206 + Rituximab | BI-1206 Rituximab | 0 | 1 |